FDA Finds Rare Neurological Disorder Is ‘Potential Risk’ With Pfizer RSV Vaccine
The Food and Drug Administration (FDA) stated that two older adults who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were subsequently diagnosed with the rare neurological disorder Guillain-Barré syndrome.
Briefing documents (pdf) released on Feb. 24 ahead of this week’s meeting of the Vaccines and Related Biological Products Advisory Committee flagged the two cases of the disorder and stated that Pfizer’s vaccine poses a potential risk. -- More...
View Comments
The Epoch Times: “A Fresh Look at Our Changing World”
The Epoch Times is a privately held news media company. The center is in New York, but our network of local reporters throughout the world uncovers stories that are authentically local, yet also globally relevant. Our independence enables us to report widely and present a diversity of opinions.
We have offices in 30 countries across five continents, and our content is published in 17 languages. We are proud to offer print and web editions in Chinese, English, German, French, Spanish, Hebrew, Russian, Japanese, Korean and Indonesian, as well as web versions in Ukrainian, Bulgarian, Romanian, Czech, Slovak, Vietnamese and Swedish.